<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Arcuate POMC Neurons</th>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Anorexigenic Metabolic Sensor Neuron</td>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Neuron > Hypothalamic > Arcuate > POMC</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Arcuate Nucleus of Hypothalamus</td>
</tr>
<tr>
<td class="label">Marker Genes</td>
<td>POMC, CART, α-MSH, β-Endorphin, MC3R, MC4R, LEPR</td>
</tr>
<tr>
<td class="label">Allen Atlas ID</td>
<td>Consult Allen Brain Atlas</td>
</tr>
<tr>
<td class="label">Neurotransmitters</td>
<td>α-MSH, β-Endorphin, ACTH, CART</td>
</tr>
<tr>
<td class="label">Primary Receptors</td>
<td>LePR, MC3R, MC4R, Insulin Receptor, GLP-1R</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4042033](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042033)</td>
</tr>
<tr>
<td class="label">Target Region</td>
<td>Neuropeptide</td>
</tr>
<tr>
<td class="label">Paraventricular Nucleus (PVN)</td>
<td>α-MSH</td>
</tr>
<tr>
<td class="label">Lateral Hypothalamus</td>
<td>α-MSH, β-Endorphin</td>
</tr>
<tr>
<td class="label">Preoptic Area</td>
<td>α-MSH</td>
</tr>
<tr>
<td class="label">Dorsal Raphe</td>
<td>β-Endorphin</td>
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Arcuate POMC Neurons</th>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Anorexigenic Metabolic Sensor Neuron</td>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Neuron > Hypothalamic > Arcuate > POMC</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Arcuate Nucleus of Hypothalamus</td>
</tr>
<tr>
<td class="label">Marker Genes</td>
<td>POMC, CART, α-MSH, β-Endorphin, MC3R, MC4R, LEPR</td>
</tr>
<tr>
<td class="label">Allen Atlas ID</td>
<td>Consult Allen Brain Atlas</td>
</tr>
<tr>
<td class="label">Neurotransmitters</td>
<td>α-MSH, β-Endorphin, ACTH, CART</td>
</tr>
<tr>
<td class="label">Primary Receptors</td>
<td>LePR, MC3R, MC4R, Insulin Receptor, GLP-1R</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4042033](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042033)</td>
</tr>
<tr>
<td class="label">Target Region</td>
<td>Neuropeptide</td>
</tr>
<tr>
<td class="label">Paraventricular Nucleus (PVN)</td>
<td>α-MSH</td>
</tr>
<tr>
<td class="label">Lateral Hypothalamus</td>
<td>α-MSH, β-Endorphin</td>
</tr>
<tr>
<td class="label">Preoptic Area</td>
<td>α-MSH</td>
</tr>
<tr>
<td class="label">Dorsal Raphe</td>
<td>β-Endorphin</td>
</tr>
<tr>
<td class="label">Nucleus Tractus Solitarius</td>
<td>α-MSH</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Appetite Suppression</td>
<td>α-MSH release activates MC4R in PVN → reduced food intake</td>
</tr>
<tr>
<td class="label">Increased Energy Expenditure</td>
<td>MC4R activation in preoptic area → increased thermogenesis</td>
</tr>
<tr>
<td class="label">Glucose Regulation</td>
<td>Direct projections to pancreas-controlling brain regions</td>
</tr>
<tr>
<td class="label">Reward Modulation</td>
<td>β-endorphin release modulates mesolimbic dopamine system</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Therapeutic Approach</td>
</tr>
<tr>
<td class="label">MC4R</td>
<td>Agonists (Setmelanotide)</td>
</tr>
<tr>
<td class="label">POMC Expression</td>
<td>Gene therapy</td>
</tr>
<tr>
<td class="label">Leptin Signaling</td>
<td>Sensitizers</td>
</tr>
<tr>
<td class="label">PCSK1</td>
<td>Enzyme inhibitors</td>
</tr>
</table>
Pro-opiomelanocortin (POMC) [neurons](/entities/neurons) in the arcuate nucleus of the hypothalamus represent the primary anorexigenic (appetite-suppressing) neuronal population essential for energy homeostasis. These neurons produce α-melanocyte-stimulating hormone (α-MSH) which activates melanocortin receptors to reduce food intake and increase energy expenditure. They play critical roles in metabolic regulation and are functionally opposite to [NPY/AgRP neurons](/cell-types/npy-agrp-neurons). [@pomc2010]
POMC neurons serve as the central executioners of the melanocortin system, integrating signals from multiple metabolic hormones including leptin, insulin, and ghrelin to regulate feeding behavior, energy expenditure, glucose homeostasis, and body weight. Dysfunction in these neurons contributes to obesity, metabolic syndrome, and the metabolic disturbances observed in neurodegenerative diseases including [Alzheimer's Disease](/diseases/alzheimers-disease) and [Parkinson's Disease](/diseases/parkinsons-disease). [@leptinpomc2011]
<!-- multi-taxonomy-enrichment -->
POMC neurons express a distinctive set of molecular markers that define their identity and function:
POMC neurons exhibit characteristic electrophysiological signatures:
POMC neurons display activity states that correlate with metabolic status:
POMC neurons receive synaptic input from multiple neuronal populations:
POMC neuron axons project to key brain regions:
The [leptin-melanocortin pathway](/mechanisms/leptin-signaling-neurodegeneration) represents the central metabolic regulatory circuit:
POMC neurons integrate multiple metabolic signals to regulate energy balance:
POMC neuron dysfunction is implicated in the metabolic disturbances characteristic of Alzheimer's Disease:
Single-cell transcriptomic studies have characterized POMC neurons:
Setmelanotide, an MC4R agonist, has been FDA-approved for rare genetic obesity disorders:
acth2018, ACTH and cortisol regulation - Endocrine Reviews (2018) (2018)
amyloidbeta2019, Amyloid-beta and leptin signaling - Neurobiology of Aging (2019) (2019)
cart2019, CART peptides in energy balance - Obesity (2019) (2019)
endorphin2020, β-Endorphin and reward pathways - Neuropsychopharmacology (2020) (2020)
glucose2018, Glucose sensing in hypothalamic neurons - Physiology (2018) (2018)
glucoseexcited2019, Glucose-excited POMC neurons - Diabetes (2019) (2019)
hypothalamic2017, Hypothalamic pathology in HD - Brain (2017) (2017)
insulin2017, Insulin signaling in POMC neurons - Cell Metabolism (2017) (2017)
lepr2021, LEPR signaling in hypothalamic neurons - Cell Metabolism (2021) (2021)
leptin2012, Leptin depolarization via TRPC channels - Journal of Neuroscience (2012) (2012)
leptin2015, Leptin activation of POMC neurons - Nature (2015) (2015)
leptin2019, Leptin as adipostat signal - Nature Reviews Endocrinology (2019) (2019)
leptinpomc2011, Leptin-POMC axis in energy homeostasis - Cell (2011) (2011)
mch2017, MCH and POMC interactions - Neuropeptides (2017) (2017)
mcr2013, MC4R in energy homeostasis - Nature (2013) (2013)
mcr2016, MC3R autocrine regulation - Cell Metabolism (2016) (2016)
melanocortin2020, Melanocortin system in PD - Journal of Neural Transmission (2020) (2020)
msh2019, α-MSH and melanocortin signaling - Peptides (2019) (2019)
npyagrp2018, NPY/AgRP inhibition of POMC - Nature Neuroscience (2018) (2018)
orexin2015, Orexin modulation of POMC neurons - Journal of Neuroscience (2015) (2015)
perivascular2018, Perivascular neurons and metabolic sensing - Cell Metabolism (2018) (2018)
pomc2010, POMC neurons and satiety signaling - Nature (2010) (2010)
pomc2015, POMC processing by PCSK1/PCSK2 - Endocrinology (2015) (2015)
setmelanotide2017, Setmelanotide in POMC deficiency - New England Journal of Medicine (2017) (2017)
setmelanotide2018, Setmelanotide in LEPR deficiency - Nature Medicine (2018) (2018)
tanycytes2017, Tanycytes and hormone sensing - Nature Reviews Neuroscience (2017) (2017)
type2019, Type 3 Diabetes hypothesis of AD - Journal of Alzheimer's Disease (2019) (2019)
weight2018, Weight loss in Parkinson's Disease - Movement Disorders (2018) (2018)